Clinical trial

Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study

NCT03646968

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-08-01

PhasePHASE2

Study timeline

Study start (actual)2018-08-01Date precision: day

Registry last updated2023-12-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Squamous Non Small Cell Lung Cancerunresolved

Interventions

Anlotinib and DocetaxelDRUG

Sponsors & collaborators

Yongchang Zhanglead sponsor

Mapped research locations

ChangshaHunan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03646968 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.